Dr. Michael Joseph Lariviere, MD

  • Philadelphia, PA
  • Radiation oncologist
NPI1184019671PAC ID6507282563
Medicare services, 2024
843
Medicare patients, 2024
399
Publications
39
Hospital affiliations
2
Industry payments
$238
Practice address
3400 Spruce St, Philadelphia, PA 19104
Practice phone
Call (215) 662-6289
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Hospital of the University of Pennsylvania

Hospital · Philadelphia, Pennsylvania

See all 4 affiliations

Find Dr. Lariviere's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Michael Joseph Lariviere is a radiation oncologist in Philadelphia, Pennsylvania

Dr. Lariviere practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Lariviere's NPI, 1184019671, was assigned on April 1, 2015. Dr. Lariviere graduated from Emory University School of Medicine in 2015. Dr. Lariviere holds Pennsylvania license MD471427.

NPI and contact details
Medicare PAC ID
6507282563
NPI enumeration date
April 1, 2015
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(215) 662-6289
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
37
Medical school graduation
2015

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Michael Joseph Lariviere practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania

Dr. Lariviere's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Source: Dmand AI Affiliation Data

Dr. Michael Joseph Lariviere is affiliated with 3 sites of care and 1 medical group

Dr. Lariviere's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Lariviere is also affiliated with Penn Presbyterian Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Lariviere to 1 more group practice or clinic, named with a free account.

See all 4 affiliations for Dr. Lariviere

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Michael Joseph Lariviere's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lariviere practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Hospital of the University of PennsylvaniaAvailable with a free account
+2 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Lariviere practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Pennsylvania and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Michael Joseph Lariviere is one of 304 radiation oncologists in Pennsylvania

Radiation oncology is Dr. Lariviere's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Lariviere is licensed in Pennsylvania.

Specialties and state licenses

  • Radiation oncology, PennsylvaniaPrimaryLicense MD471427 · taxonomy 2085R0001X

Radiation oncologists near Dr. Lariviere

Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Michael Joseph Lariviere billed Medicare for 843 services in 2024

CMS data shows 843 Medicare services from Dr. Lariviere across 14 procedure codes in 2024, for 399 Medicare patients. Medicare paid $43,467 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2024843
Medicare patients399
Paid by Medicare$43,467
Procedure codes14

Dr. Lariviere's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Imaging
2023: 4412024: 62141%
Other services
2023: 1672024: 1702%
Office and hospital visits
2023: 592024: 5212%

Dr. Lariviere compared with the Pennsylvania median for radiation oncologists, 2024

  • Dr. Lariviere
  • Pennsylvania median
Medicare services
843vs 1,02718% below
Medicare patients
399vs 1602.5 times

Medians across 308 radiation oncologists in Pennsylvania with Dmand AI profiles that report each measure.

Dr. Lariviere's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Lariviere

Need commercial claims for Dr. Lariviere?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lariviere and other radiation oncologists in Pennsylvania.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Michael Joseph Lariviere treated 399 Medicare patients in 2024, average age 72

CMS counts 399 Medicare patients who saw Dr. Lariviere in 2024. The largest group is 65 to 74, with 230 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lariviere's median patient age at 54, with 43% women.

Medicare patients, 2024399
Average age72
Average risk score1.89
Also on Medicaid8%

Dr. Lariviere's Medicare patients by age, 2024

Dr. Lariviere's Medicare patients by sex, 2024

  • Women15840%
  • Men24160%

Chronic conditions among Dr. Lariviere's Medicare patients, 2024

  1. High cholesterol75%
  2. High blood pressure74%
  3. Cancer59%
  4. Arthritis37%
  5. Ischemic heart disease32%
  6. Diabetes30%
  7. Anxiety27%
  8. Chronic kidney disease26%

Share of Medicare patients with each condition. A patient can have several.

Dr. Lariviere's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 54

Patient panel by sex, all payers

  • Women43%
  • Men56%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Michael Joseph Lariviere offers telehealth to Medicare patients

Dr. Lariviere accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lariviere as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find radiation oncologists like Dr. Lariviere by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Michael Joseph Lariviere has 39 publications on record

Dmand AI links 39 papers to Dr. Lariviere, published from 2013 to 2025. 2019 was the busiest year, with 6. The most frequent topics are Radiotherapy Dosage, Biomarkers, Tumor and Brain Neoplasms. Dr. Lariviere has published most often in Pract Radiat Oncol. Dr. Lariviere's most frequent co-authors are John Peter Plastaras, MD, Stephanie Zeng Rong Yee, MD and Elise A. Chong, MD.

Papers39
Years published2013 to 2025

Dr. Lariviere's papers by year, 2013 to 2025

Topics Dr. Lariviere writes about most

  • Radiotherapy Dosage
  • Biomarkers, Tumor
  • Brain Neoplasms
  • Proton Therapy
  • Adenocarcinoma
  • Breast Neoplasms
  • Cell-Free Nucleic Acids
  • Cell Line, Tumor

Dr. Lariviere's most frequent co-authors

Recent publications by Dr. Lariviere

See all 39 publications and co-authors

See who Dr. Lariviere researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lariviere works with, so you can find a warm path to the right radiation oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Michael Joseph Lariviere received $238 in industry payments from 2023 to 2025

CMS Open Payments shows 7 general payments to Dr. Lariviere from 2 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. GE Healthcare paid the most, $211.

General payments to Dr. Lariviere by program year, 2023 to 2025

Companies that paid Dr. Lariviere the most, 2023 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Lariviere

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Michael Joseph Lariviere graduated from Emory University School of Medicine

Dr. Lariviere graduated from Emory University School of Medicine in 2015.

  1. Medical schoolEmory University School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Michael Joseph Lariviere's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Michael Joseph Lariviere

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Michael Joseph Lariviere's NPI number?

Dr. Michael Joseph Lariviere's NPI number is 1184019671. It was assigned on April 1, 2015, and it is active in the NPI Registry.

What kind of doctor is Dr. Michael Joseph Lariviere?

Dr. Michael Joseph Lariviere is a radiation oncologist in Philadelphia, Pennsylvania. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).

Where does Dr. Michael Joseph Lariviere practice?

Dr. Lariviere practices at 3400 Spruce St, Philadelphia, PA 19104. Dr. Lariviere's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dmand AI also links Dr. Lariviere to 1 group practice or clinic.

What is Dr. Michael Joseph Lariviere's office phone number?

The practice phone on file for Dr. Lariviere is (215) 662-6289.

What is Dr. Michael Joseph Lariviere's medical license number?

Dr. Lariviere holds Pennsylvania license MD471427.

Which hospitals is Dr. Michael Joseph Lariviere affiliated with?

Dr. Lariviere practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania. Dr. Lariviere is also affiliated with Penn Presbyterian Medical Center.

What medical group is Dr. Michael Joseph Lariviere part of?

Dr. Lariviere is linked to Penn Medicine Lancaster General Health.

Does Dr. Michael Joseph Lariviere accept Medicare?

Yes. CMS data shows Dr. Lariviere billed Medicare for 843 services in 2024, and Dr. Lariviere accepts Medicare assignment.

Does Dr. Michael Joseph Lariviere offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Lariviere as offering telehealth services.

How many Medicare patients does Dr. Michael Joseph Lariviere see?

CMS counts 399 Medicare patients who saw Dr. Lariviere in 2024, with an average age of 72.

Show 6 more questionsShow fewer questions

What services does Dr. Michael Joseph Lariviere bill to Medicare?

In 2024, Dr. Lariviere's most billed Medicare services were radiation oncology (77014), medicare service (G6002) and radiation oncology (77300).

Where did Dr. Michael Joseph Lariviere go to medical school?

Dr. Lariviere graduated from Emory University School of Medicine in 2015.

Has Dr. Michael Joseph Lariviere received payments from drug or device companies?

CMS Open Payments shows $238 in general payments to Dr. Lariviere from 2 companies from 2023 to 2025. The largest total came from GE Healthcare.

How long has Dr. Michael Joseph Lariviere been practicing?

Dr. Lariviere graduated from medical school in 2015, 11 years ago.

Does Dr. Michael Joseph Lariviere do research?

Dmand AI links 39 publications to Dr. Lariviere, published from 2013 to 2025.

Who does Dr. Michael Joseph Lariviere publish with?

Dr. Lariviere's most frequent co-authors are John Peter Plastaras, MD (10 shared papers), Stephanie Zeng Rong Yee, MD (7 shared papers) and Elise A. Chong, MD (6 shared papers).

Selling to radiation oncology practices?

See radiation oncologists in Pennsylvania by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)